
Xari T 250mg/31.25mg Injection
Marketer
H & Care Incorp
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Xari T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus limiting infection spread. Administration must be solely under a doctor's guidance; strict adherence to the prescribed regimen is crucial. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require prompt medical help. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, avoid driving if experiencing somnolence or vertigo. Adequate rest, proper nutrition, and hydration are essential for optimal recovery. Your physician may order lab work to monitor treatment response.
Uses of Xari T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Xari T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xari T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xari T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Xari T 250mg/31.25mg Injection works:
Xari T Injection, containing 250mg Ceftriaxone and 31.25mg Tazobactam, employs a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xari T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xari T 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Xari T 250mg/31.25mg Injection warrants careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Xari T 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Operation of a motor vehicle is contraindicated should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xari T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Xari T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Xari T 250mg/31.25mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xari T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Xari T 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Xari T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
